Results 1 to 10 of about 43,674 (210)

Screening Strategies for High-Yield Chinese Hamster Ovary Cell Clones [PDF]

open access: yesFrontiers in Bioengineering and Biotechnology, 2022
Chinese hamster ovary (CHO) cells are by far the most commonly used mammalian expression system for recombinant expression of therapeutic proteins in the pharmaceutical industry.
Wenwen Yang   +8 more
doaj   +2 more sources

4-(2,5-Dimethyl-1H-pyrrol-1-yl)-N-(2,5-dioxopyrrolidin-1-yl) benzamide improves monoclonal antibody production in a Chinese hamster ovary cell culture. [PDF]

open access: yesPLoS ONE, 2021
There is a continuous demand to improve monoclonal antibody production for medication supply and medical cost reduction. For over 20 years, recombinant Chinese hamster ovary cells have been used as a host in monoclonal antibody production due to ...
Yuichi Aki   +4 more
doaj   +2 more sources

Chinese hamster ovary cell line DXB-11: chromosomal instability and karyotype heterogeneity [PDF]

open access: yesMolecular Cytogenetics, 2021
Background Chinese hamster ovary cell lines, also known as CHO cells, represent a large family of related, yet quite different, cell lines which are metabolic mutants derived from the original cell line, CHO-ori.
Victoria I. Turilova   +2 more
doaj   +2 more sources

Genetic drivers of Chinese hamster ovary cell proliferation revealed by functional genomics [PDF]

open access: yesiScience
Summary: Cell lines used in biopharmaceutical manufacturing are engineered to optimize protein yield, quality, and production speed. Cellular growth rate is a key bottleneck in the development of biopharmaceutical production cell lines.
Jannis Marzluf   +4 more
doaj   +2 more sources

Comparative omics profiling reveals differences in biomass, energy production, and vesicle transport between CHO and fast-growing CHL-YN cells [PDF]

open access: yesScientific Reports
Chinese hamster lung (CHL)-YN cells are promising novel hosts for producing therapeutic antibodies with the potential to shorten the research, development, and manufacturing timelines in biopharmaceutical production.
Yu Tsunoda   +6 more
doaj   +2 more sources

Data for engineering lipid metabolism of Chinese hamster ovary (CHO) cells for enhanced recombinant protein production

open access: yesData in Brief, 2020
The data presented in this article relates to the manuscript entitled ‘Engineering of Chinese hamster ovary cell lipid metabolism results in an expanded ER and enhanced recombinant biotherapeutic protein production’, published in the Journal Metabolic ...
James D. Budge   +11 more
doaj   +1 more source

Generation of induced pluripotent stem cells from Chinese hamster embryonic fibroblasts

open access: yesStem Cell Research, 2017
We derived a stable cell line from Chinese hamster embryonic fibroblasts by transduction of four mouse transcription factors (M3O, Sox2, Klf4, and n-Myc) using a lentiviral vector.
Haiyun Pei   +7 more
doaj   +1 more source

Sterilization of PAN/Gelatine Nanofibrous Mats for Cell Growth [PDF]

open access: yesTekstilec, 2019
Nanofibrous mats can be used as a substrate for eukaryotic cell growth in biotechnology, tissue engineering, etc. Several adherent cells (e.g. human fibroblasts) have been shown to grow well on fine fibres.
Daria Wehlage   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy